Neutral
ACADIA Pharmaceuticals stock (US0042251084): Biotech decline amid CNS focus
ACADIA Pharmaceuticals (ACAD) has seen a 19.2% stock decline year-to-date in 2026, dropping to $21.57 per share amidst competitive pressures in the ce...